loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Drug Master Files (DMF) of Ponatinib Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MSN Laboratories (1)

02 Signa S.A. de C.V. (1)

03 Viatris (1)

filter

01 PONATINIB HYDROCHLORIDE (3)

filter

01 India (1)

02 Mexico (1)

03 U.S.A (1)

filter

01 Active (3)

filter

01 Complete (2)

02 Blank (1)

URL Supplier Web Content
37854
Active
2022-12-31
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
35413
Active
2020-12-16
Complete
2021-01-29
2020-11-27
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
32340
Active
2018-01-07
Complete
2022-07-22
2022-06-06
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 943319-70-8 / Ponatinib API manufacturers, exporters & distributors?

Ponatinib manufacturers, exporters & distributors 1

84

PharmaCompass offers a list of Ponatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ponatinib manufacturer or Ponatinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ponatinib manufacturer or Ponatinib supplier.

PharmaCompass also assists you with knowing the Ponatinib API Price utilized in the formulation of products. Ponatinib API Price is not always fixed or binding as the Ponatinib Price is obtained through a variety of data sources. The Ponatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ponatinib

Synonyms

943319-70-8, Ap24534, Ponatinib (ap24534), Ap 24534, Ap-24534, 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Cas Number

943319-70-8

Unique Ingredient Identifier (UNII)

4340891KFS

About Ponatinib

Ponatinib is an orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome.

Ponatinib Manufacturers

A Ponatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ponatinib, including repackagers and relabelers. The FDA regulates Ponatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ponatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ponatinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ponatinib Suppliers

A Ponatinib supplier is an individual or a company that provides Ponatinib active pharmaceutical ingredient (API) or Ponatinib finished formulations upon request. The Ponatinib suppliers may include Ponatinib API manufacturers, exporters, distributors and traders.

click here to find a list of Ponatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ponatinib USDMF

A Ponatinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Ponatinib active pharmaceutical ingredient (API) in detail. Different forms of Ponatinib DMFs exist exist since differing nations have different regulations, such as Ponatinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ponatinib DMF submitted to regulatory agencies in the US is known as a USDMF. Ponatinib USDMF includes data on Ponatinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ponatinib USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ponatinib suppliers with USDMF on PharmaCompass.

Ponatinib Manufacturers | Traders | Suppliers

Ponatinib Manufacturers, Traders, Suppliers 1
26

We have 3 companies offering Ponatinib

Get in contact with the supplier of your choice:

  1. MSN Laboratories
  2. Signa S.A. de C.V.
  3. Viatris
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY